Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
about
PP2A: The Wolf in Sheep's Clothing?11q deletion in neuroblastoma: a review of biological and clinical implications.The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiationCIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Mysteries of TGF-β Paradox in Benign and Malignant Cells.Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients.Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.CIP2A acts as a scaffold for CEP192-mediated microtubule organizing center assembly by recruiting Plk1 and aurora A during meiotic maturation.HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130.Targeting of epigenetic regulators in neuroblastoma.CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells
P2860
Q28088747-B90B0B28-62CC-47A1-81D4-1993AEC0DAA3Q32174267-9353B16A-96FA-4010-B017-794662F9139EQ33557525-34DCA423-510C-4D61-BA69-6146B74D2F4FQ36260616-78C633CC-50E8-429F-8D42-C332F9D37DA9Q38214771-18728E2A-2767-476A-847F-76BA1FFD4DB9Q38228491-2BA52453-E089-4F4D-9C79-99A4480FD9BEQ38335027-C85BA866-CA03-41EB-9B86-D0866AC0FE69Q38891984-10CA9908-F578-43D7-97A1-518033BA59D7Q40189561-4D26CEB5-39BD-4F4E-B53D-9089035BA6FFQ42152408-919C6396-C00F-46D5-BAAA-983AA7B7CB16Q47110572-B9343DA5-4564-46BE-9D2D-828B578F2B80Q47649638-3C91E833-0F93-47B8-9781-4902A7B1A6E0Q50317222-9B04C453-F959-4F23-8028-9CA464834476Q52560224-277C2295-806D-4143-B921-B95900B3D9F3Q58788836-AD6DFE65-5920-4325-9264-224BB563F724
P2860
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@ast
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@en
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@nl
type
label
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@ast
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@en
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@nl
prefLabel
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@ast
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@en
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@nl
P2093
P2860
P50
P1433
P1476
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
@en
P2093
Agnieszka Szwajda
Anchit Khanna
Anni Laine
Ari Ristimäki
Caj Haglund
Ilona Schreck
John Pimanda
Juha Klefström
Kristina A Cole
Merja Helenius
P2860
P304
P356
10.1158/0008-5472.CAN-13-1002
P407
P577
2013-11-15T00:00:00Z